Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-09-26
1985-06-04
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31505
Patent
active
045214212
ABSTRACT:
Sexual dysfunction in mammals is treated with a trans-(.+-.)- or trans-(-)-2-amino-4-permissibly-substituted-6-loweralkyl or allyl octahydropyrimido[4,5-g]quinoline or a pharmaceutically-acceptable acid addition salt thereof.
REFERENCES:
patent: 3793324 (1974-02-01), Penzer
patent: 4198415 (1980-04-01), Kornfeld et al.
Kaplan, Disorders of Sexual Desire, Brunner, Mazel Book Inc., N.Y., N.Y. 1979, only Appendix Table 1 attached.
Hollister, Life Sciences, 17, 661 (1975).
Spark et al., Jama , 243, 750 (1980).
Gessa and Tagliamonte, Life Sciences, 14, 425 (1974).
Malmnas, Acta. Physiologica Scandanavica, Suppl. 395, 47-68 and 69-128, (1973).
M. Da Prada et al., Brain Research, 57, 383, (1973).
Benassi-Benelli et al., Arch. int. Pharmacodyn., 242, 241, (1979).
Falaschi et al., Apomorphine and Other Dopaminomimetics, vol. 1, 117-121, (Gessa & Corsini Eds.-Raven Press, N.Y. 1981).
Poggioli et al., Riv. di Farm. & Terap., 9, 213, (1978).
Ahlenius et al., J. Neural Transmission, 54, 165, (1982).
Tagliamonte et al., Pharm. Biochem, Behav., 2, 257, (1974).
Ahlenius et al., European J. Pharm., 64, 47, (1980).
Hlinat et al., Psychopharm., 79, 231, (1983).
Silbergeld and Hruska, Euro. J. Pharm., 58, 1, (1979).
Hyyppa et al., Acta. Neurologia Scand., 46, Suppl. 43, p. 223, (1970).
Bommer et al., Lancet, 496, (1979).
Pierini and Nusimovich, Archives of Andrology, 6, 347, (1981).
Ambrosi et al., Clinical Endocrinology, 7, 417, (1977).
Pierini et al., Int. J. Fertil., 24, 214, (1979).
Morales et al., J. Urol., 128, 45, (1982).
Benkert, Mod. Probl. Pharmacopsych., 15, 158, (1980).
Buffum, J. Psychoactive Drugs, 14, 5, 28-31, (1982).
March, Drugs, 17, 349, (1979).
Lees and Stern, Lancet, 246, 577, (1981).
Maneschi et al., Hormone Res., 14, 79, (1981).
Perryman and Thorner, J. Andrology, 5, 233, (1981).
Rocco et al., Arch. Andrology, 10, 179, (1983).
Bairinos et al., Psychoeneuroendocrinology, 6, 341, (1981).
Kedia and Markland, Urology, 111, 569, (1975).
Kimura et al., Andrologia, 14, 341, (1982).
Hamburger-Bar and Rigter, European J. Pharm., 32, 357, (1975).
Foreman and Moss, Physiology & Behavior, 22, 283, (1979).
Fuxe et al., Subcellular Mechanisms in Reproductive Neuro-endocrinology, Chapter 11, (Eds. Naftolin, Ryan and Davies, Elsevier, Amsterdam, The Netherlands, 1976).
Everitt and Fuxe, Neuroscience Letters, 4, 209, (1977).
Renshaw, Mod. Probl. Pharmacopsych., 15, 145, (1980) (pp. 145 and 151 only supplied).
Eli Lilly and Company
Rowe James L.
Schenkman Leonard
Whale Arthur R.
LandOfFree
Treatment of sexual dysfunction does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of sexual dysfunction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of sexual dysfunction will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-828351